Laman UtamaEDIT • NASDAQ
add
Editas Medicine Inc
Tutup sebelumnya
$5.21
Julat hari
$5.17 - $5.65
Julat tahun
$4.45 - $11.69
Permodalan pasaran
461.35J USD
Bilangan Purata
2.33J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2024info | Perubahan T/T |
|---|---|---|
Hasil | 1.14J | -88.48% |
Perbelanjaan pengendalian | 19.34J | -15.95% |
Pendapatan bersih | -61.95J | -26.34% |
Margin untung bersih | -5.46K | -996.50% |
Pendapatan bagi setiap syer | -0.76 | -7.04% |
EBITDA | -65.58J | -32.71% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 296.17J | -6.99% |
Jumlah aset | 440.35J | -5.12% |
Jumlah liabiliti | 145.95J | -0.47% |
Jumlah ekuiti | 294.40J | — |
Syer tertunggak | 82.24J | — |
Harga kepada buku | 1.46 | — |
Pulangan pada aset | -35.65% | — |
Pulangan pada modal | -46.90% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -61.95J | -26.34% |
Tunai daripada operasi | -49.87J | -39.43% |
Tunai daripada pelaburan | -4.74J | -120.39% |
Tunai daripada pembiayaan | 192.00K | — |
Perubahan bersih dalam tunai | -54.42J | -335.37% |
Aliran tunai bebas | -23.33J | -9.15% |
Perihal
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Diasaskan
Nov 2013
Tapak web
Pekerja
265
